Trials / Unknown
UnknownNCT03034382
Morphine and/or Nalbuphine as Adjuvants in Ultrasound Guided Interscalene Block: for Shoulder Surgeries
Adjuvants to Ultrasonic Guided Interscalene Block In Arthroscopic Rotator Cuff Repair; Morphine and/or Nalbuphine
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
the aim of this study is to evaluate the duration of analgesia when either morphine or nalbuphine or both are used as adjuvants in sonar guided interscalene brachial plexus block for arthroscopic rotator cuff repair.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphine | 5 mg morphine in 5 ml volume are injected perineurally as adjuvants for 10 ml of lidocaine + epinephrine 1:400,000 in ultrasound guided interscalene block |
| DRUG | Nalbuphine | 5 mg nalbuphine in 5 ml volume are injected perineurally as adjuvants for 10 ml of lidocaine + epinephrine 1:400,000 in ultrasound guided interscalene block |
| DRUG | Bupivacaine 0.5% | 10 ml of 1% lidocaine +1:400,000 epinephrine and 5 ml of bupivacaine 0.5% injected perineurally in interscalene block |
| DRUG | Lidocaine Hydrochloride 1% and epinephrine 1:400,000 | 10 ml of 1% lidocaine and 1:400,000 epinephrine were injected perineurally in interscalene block |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-05-01
- Completion
- 2017-06-01
- First posted
- 2017-01-27
- Last updated
- 2017-05-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03034382. Inclusion in this directory is not an endorsement.